tiprankstipranks
Is IMGN a Buy, Before Earnings?
PremiumPre-EarningsIs IMGN a Buy, Before Earnings?
2M ago
Immunogen Shareholders Approve Merger with AbbVie Inc.
PremiumCompany Announcements
Immunogen Shareholders Approve Merger with AbbVie Inc.
3M ago
ImmunoGen’s Merger with AbbVie Awaits Shareholder Approval
PremiumCompany Announcements
ImmunoGen’s Merger with AbbVie Awaits Shareholder Approval
3M ago
M & A News: AbbVie (NYSE:ABBV) Doubles Down on Acquisitions, Buys CERE for $8.7B
PremiumMarket NewsM & A News: AbbVie (NYSE:ABBV) Doubles Down on Acquisitions, Buys CERE for $8.7B
4M ago
ImmunoGen’s sBLA for Elahere in ovarian cancer granted priority review by FDA
PremiumThe Fly
ImmunoGen’s sBLA for Elahere in ovarian cancer granted priority review by FDA
5M ago
ImmunoGen downgraded to Neutral from Overweight at Piper Sandler
PremiumThe Fly
ImmunoGen downgraded to Neutral from Overweight at Piper Sandler
5M ago
ImmunoGen downgraded to Neutral from Buy at Guggenheim
PremiumThe FlyImmunoGen downgraded to Neutral from Buy at Guggenheim
5M ago
ImmunoGen downgraded to Market Perform from Outperform at BMO Capital
PremiumThe Fly
ImmunoGen downgraded to Market Perform from Outperform at BMO Capital
5M ago
ImmunoGen downgraded to Hold from Buy at Deutsche Bank
PremiumThe Fly
ImmunoGen downgraded to Hold from Buy at Deutsche Bank
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100